BofA Securities Downgrades Harmony Biosciences Holdings Inc. (HRMY) to Underperform, 'lack of catalysts + limited valuation upside'
Tweet Send to a Friend
(Updated - January 2, 2024 5:24 AM EST)
BofA Securities analyst Jason Gerberry downgraded Harmony Biosciences Holdings Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry downgraded Harmony Biosciences Holdings Inc. (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
